Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosaEllie Rashidghamat, John A. McGrath, Tendai Kadiyirire et al.|Journal of the American Academy of Dermatology|2019Cited by 115
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cellsL.C.J. te Boome, Jürgen Kuball, Maud Plantinga et al.|Leukemia|2015Cited by 75
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profileLotte E. van der Wagen, Jürgen Kuball, Alberto Miranda Bedate et al.|Bone Marrow Transplantation|2020Cited by 18
Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stromal cells expanded with platelet lysate - a phase I/II studyLotte van der Wagen, J.H.E. Kuball, Liane te Boome et al.|Cytotherapy|2014Cited by 1